Consortium to develop COVID-19 vaccine

摘要

University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19 have started screening healthy volunteers They are working on the ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region.The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won't be ready for some weeks.Professor Adrian Hill,Director of the Jenner Institute at the University of Oxford,said: The Oxford team had exceptional experience of a rapid vaccine response,such as to the Ebola outbreak in West Africa in 2014.This is an even greater challenge.Vaccines are being designed from scratch and progressed at an unprecedented rate.The upcoming trial will be critical for assessing the feasibility of vaccination against COVID-19 and could lead to early deployment.”